Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008370 · ClinicalTrials.gov registry record · Phase 4
Exparel in Minimally Invasive Cardiac Surgery
A Phase 4 study, sponsored by Maimonides Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT02008370 is a Phase 4 study that was terminated before completion, run by Maimonides Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT02008370, a Phase 4 study, was terminated before completion, sponsored by Maimonides Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The investigators are presently using Exparel, a slow released local anesthestic, in patients undergoing minimally invasive cardiac surgery. The primary objective of this study is to assess the efficacy of EXPAREL when delivered into the thoracotomy and chest tube sites to provide prolonged postoperative analgesia in patients undergoing minimally invasive cardiac surgery. Efficacy will be assessed by: the effectiveness of analgesia as measured by the subject's overall postoperative pain scores and postsurgical analgesic use.
Interventions
- DRUG Exparel infiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02008370
The ClinicalTrials.gov registry entry for NCT02008370 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exparel infiltration is the first listed.
NCT02008370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02008370 about?
NCT02008370 is a clinical study titled "Exparel in Minimally Invasive Cardiac Surgery". The investigators are presently using Exparel, a slow released local anesthestic, in patients undergoing minimally invasive cardiac surgery. The primary objective of this study is to assess the efficacy of EXPAREL when delivered into the thoracotomy and chest tube sites to provide prolonged postoper...
What is the current status of trial NCT02008370?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2013-11. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02008370?
The interventions under investigation include: Exparel infiltration (DRUG).
Who is sponsoring clinical trial NCT02008370?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.